Page last updated: 2024-12-08

1-kestose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-kestose: A Prebiotic with Potential

1-kestose, also known as kestose or kestose 6G, is a **trisaccharide**, a type of sugar composed of three monosaccharide units: **glucose, fructose, and fructose**. It's found naturally in some plants, particularly in **chicory root**.

**Why is it important for research?**

1-kestose is gaining increasing attention due to its potential as a **prebiotic**, a substance that promotes the growth of beneficial bacteria in the gut. These beneficial bacteria, known as **probiotics**, play a crucial role in maintaining gut health and overall well-being.

Here are some key reasons why 1-kestose is important for research:

* **Gut Health:** 1-kestose can selectively promote the growth of specific beneficial bacteria like **Bifidobacteria and Lactobacilli**, which contribute to:
* Improved digestion and nutrient absorption
* Enhanced immune function
* Reduced inflammation
* Potential for preventing and treating certain gut disorders

* **Metabolic Health:** Research suggests that 1-kestose may have positive effects on metabolic health, potentially leading to:
* Improved blood sugar control
* Reduced insulin resistance
* Lowered cholesterol levels
* Weight management

* **Cognitive Function:** Some studies suggest that 1-kestose may positively influence cognitive function and memory.

* **Cancer Prevention:** Research is exploring the potential of 1-kestose in preventing certain types of cancer.

* **Drug Delivery:** 1-kestose has been investigated for its potential in drug delivery systems, particularly for targeted delivery of medications to the gut.

**Current Research:**

Ongoing research continues to explore the various health benefits of 1-kestose. Scientists are investigating its mechanisms of action, optimal dosage, and long-term effects on human health.

**Conclusion:**

1-kestose is a promising prebiotic with potential applications in improving gut health, metabolic health, and overall well-being. Continued research in this area is crucial for understanding its full potential and paving the way for future applications in healthcare and nutrition.

1-kestose: sugar found in vegetables; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-kestose : A trisaccharide found in vegetables consisting of beta-D-fructofuranose having beta-D-fructofuranosyl and alpha-D-glucopyranosyl residues attached at the 1- and 2-positions respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID440080
CHEBI ID16885
SCHEMBL ID21351379
MeSH IDM0196231

Synonyms (48)

Synonym
o-beta-d-fructofuranosyl-(2->1)-o-beta-d-fructofuranosyl-(2->1)-alpha-d-glucopyranoside
1-kestotriose ,
[beta-d-fru-(2->1)]2-alpha-d-glup
1(f)-beta-d-fructosylsucrose
470-69-9
CHEBI:16885 ,
beta-d-fru-(2->1)-beta-d-fru-(2->1)-alpha-d-glup
1-kestose
alpha-d-fructofuranosyl-alpha-d-fructofuranosyl-alpha-d-glucopyranoside
C03661
beta-d-fructofuranosyl-(2->1)-beta-d-fructofuranosyl alpha-d-glucopyranoside
1f-beta-d-fructosylsucrose
1f-(beta-d-fructofuranosyl)sucrose
kestose, 1-
2AEZ
K0032
o-beta-d-fructofuranosyl-(2.1)-beta-d-fructofuranosyl-alpha-d-glucopyranoside
02ln7o412c ,
unii-02ln7o412c
einecs 207-429-4
S9109
12505-31-6
alpha-d-glucopyranoside, beta-d-fructofuranosyl, mono-d-fructofuranoside
o-d-fructosylsucrose
sucrose, o-d-fructosyl-
W-202825
wurcs=2.0/2,3,2/[a2122h-1a_1-5][ha122h-2b_2-5]/1-2-2/a1-b2_b1-c2
AC-35097
(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-2-({[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
J196.187J ,
1-kestose, analytical standard
1-fructosylsucrose
.alpha.-d-glucopyranoside, o-.beta.-d-fructofuranosyl-(2->1)-.beta.-d-fructofuranosyl
glucopyranoside, o-.beta.-d-fructofuranosyl-(2->1)-.beta.-d-fructofuranosyl, .alpha.-d-
gf2 ,
1f-.beta.-d-fructosylsucrose
gf-2
beta-d-fruf-(2->1)-beta-d-fruf-(2->1)-alpha-d-glup
(2r,3r,4s,5s,6r)-2-(((2s,3s,4s,5r)-2-((((2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
AKOS037515274
SCHEMBL21351379
Q27102129
HY-N2579
CS-0022917
CCG-269723
AS-56121
A872211
PD087928
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trisaccharide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
fructan biosynthesis09
fructan degradation06
fructan biosynthesis110
fructan degradation07
Fructan biosynthesis06
Fructan degradation04

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, fructan 1-exohydrolase IIaCichorium intybus (chicory)Ki3,500.00003,500.00003,500.00003,500.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2007The New phytologist, , Volume: 174, Issue:1
Insights into the fine architecture of the active site of chicory fructan 1-exohydrolase: 1-kestose as substrate vs sucrose as inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (10.77)18.2507
2000's18 (27.69)29.6817
2010's25 (38.46)24.3611
2020's15 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.94 (24.57)
Research Supply Index4.25 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index55.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (4.55%)5.53%
Reviews2 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (92.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]